Clinical Trial: The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06403150) titled 'The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus' on Feb. 21.

Brief Summary: Status epilepticus (SE) is an emergency, life-threatening medical condition that may cause irreversible cerebral damage. Therefore, the rapid and secure cessation of seizures and resuscitation is crucial. Potent gamma-aminobutyric acid agonists, including benzodiazepines, are recommended as first-line treatments. For the complete cessation of SE and prevention of recurrence, long-acting antiepileptic drugs (e.g.- FPHT) are also required as second-line treatments along with short-acting benzodiazepines. Intravenous ...